Positioning no disclosures inside 60 days, left as found
Options put/call open interest 2.23, read 2026-11-05
Ethical passes the values gate
Price311.74 USD
Fair value484.35
Ethical score91.4/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-03Read Distribution324.55-3.9% to today ✓Markup gives way to Distribution after a 17% slide in 18 weeks
2026-07-02Read Markup393.35-20.7% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
F5, Inc. holds its Distribution at $311.74. Elevated stress, defensive posture warranted, held for 3 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 3 days
Price at the screen
$311.74
Valuation
27.02 trailing · 16.89 forward price to earnings
Values screen
PASS· score 91.4
Beta
1.03
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
4.14%
Below 33%
Interest-bearing debt is just 4.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.25%
Below 33%
Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit.
Pass
Receivables
27.83%
Below 49%
Money owed to the company is 27.8% of assets, under the 49% limit.
Pass
Revenue purity
1.32%
Below 5%
Only 1.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
F5, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 4%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FFIV's ethical verdict changes
Today FFIV passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 36% discount to our $484.35 fair value, strong competitive moat, 13.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 35.6% discount to the base estimate.
Where our models see it going: fair-value estimate $484.35, with a range of $390.52 to $623.48, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Cloud security firm priced beyond its value
Every time a company moves apps across clouds it still needs reliable security and delivery. F5 built that infrastructure and now earns a 22 percent profit margin with 20 percent ROE and an 11 percent revenue rise. A strong moat supports those returns, yet the shares trade at 23.1 times forward earnings while our fair value sits only 6 percent higher.
That leaves little room for error. Analysts already see a median target below the current price and rate the stock a hold. The ethical screen clears, yet the opportunity rating remains overvalued because the market has already paid for the quality on show.
Growth could slow as cloud spending normalises, and any multiple compression would erase the thin margin of safety quickly. The business itself looks solid, but the entry point does not.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FFIV trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 26.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362.
2026-10-27Markup$442.03+0.0%Entry 15
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markup$442.03+0.0%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 26% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markup$442.03+0.0%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markup$442.03+0.0%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markup$442.03+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markup$442.03+0.0%Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markup$442.03+0.0%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markup$442.03-7.9%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.9% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markup$479.83+10.2%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 33%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (10 analysts) rates it hold, with a mean price target of $362.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
